Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan F Murray

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Cell Metabolism|February 7, 2006
miR-122 regulation of lipid metabolism revealed by in vivo antisense targetingChristine Esau, Scott Davis, Susan F Murray, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2009
SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic ratsDerek M Erion, Shin Yonemitsu, Yongzhan Nie, et al.
The Journal of Biological Chemistry|May 5, 2007
Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage diseaseKyle W Sloop, Aaron D Showalter, Amy L Cox, et al.
Lancet (London, England)|June 27, 2014
Country experience with strengthening of health systems and deployment of midwives in countries with high maternal mortalityWim Van Lerberghe, Zoe Matthews, Endang Achadi, et al.
Cell Metabolism|March 4, 2009
The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistanceYoshio Nagai, Shin Yonemitsu, Derek M Erion, et al.
Nature Biotechnology|May 1, 2019
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic indexWen Shen, Cheryl L De Hoyos, Michael T Migawa, et al.
Nucleic Acids Research|July 5, 2014
Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in miceThazha P Prakash, Mark J Graham, Jinghua Yu, et al.
Cell Metabolism|December 1, 2009
Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding proteinDerek M Erion, Irena D Ignatova, Shin Yonemitsu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2002
PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic miceBradley A Zinker, Cristina M Rondinone, James M Trevillyan, et al.
Journal of Medicinal Chemistry|February 26, 2016
Comprehensive Structure-Activity Relationship of Triantennary N-Acetylgalactosamine Conjugated Antisense Oligonucleotides for Targeted Delivery to HepatocytesThazha P Prakash, Jinghua Yu, Michael T Migawa, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Cell Metabolism|February 7, 2006
miR-122 regulation of lipid metabolism revealed by in vivo antisense targetingChristine Esau, Scott Davis, Susan F Murray, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2009
SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic ratsDerek M Erion, Shin Yonemitsu, Yongzhan Nie, et al.
The Journal of Biological Chemistry|May 5, 2007
Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage diseaseKyle W Sloop, Aaron D Showalter, Amy L Cox, et al.
Lancet (London, England)|June 27, 2014
Country experience with strengthening of health systems and deployment of midwives in countries with high maternal mortalityWim Van Lerberghe, Zoe Matthews, Endang Achadi, et al.
Cell Metabolism|March 4, 2009
The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistanceYoshio Nagai, Shin Yonemitsu, Derek M Erion, et al.
Nature Biotechnology|May 1, 2019
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic indexWen Shen, Cheryl L De Hoyos, Michael T Migawa, et al.
Nucleic Acids Research|July 5, 2014
Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in miceThazha P Prakash, Mark J Graham, Jinghua Yu, et al.
Cell Metabolism|December 1, 2009
Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding proteinDerek M Erion, Irena D Ignatova, Shin Yonemitsu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2002
PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic miceBradley A Zinker, Cristina M Rondinone, James M Trevillyan, et al.
Journal of Medicinal Chemistry|February 26, 2016
Comprehensive Structure-Activity Relationship of Triantennary N-Acetylgalactosamine Conjugated Antisense Oligonucleotides for Targeted Delivery to HepatocytesThazha P Prakash, Jinghua Yu, Michael T Migawa, et al.
Pageof 6